Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1061 results for "bse healthcare"

Sensex falls on global growth worries, weak China data
Times of India

Sensex Slips 22 Points in Late Morning Trade

The benchmark BSE Sensex slipped marginally by 22 points in late morning trade following profit-booking in FMCG, healthcare and IT stocks on caution ahead of key economic data tomorrow. Also, the market turned range-bound from initial surge as ... Outlook India, 3 weeks ago
[x]  

Birla Sun Life Pure Value: Spice up your returns with this mid-cap fund

Mid- and small-caps have rallied for most part of the last two years. The BSE mid-cap index managed to deliver a healthy 7.4 per cent return in the not-so-happening market of 2015, when broader indices, the Nifty and the Sensex, lost 4 per cent and ...
 Hindu Business Line4 days ago

FY16 results on May 13, 2016 (SCRIPCODE: 532321)

Cities Business & Finance ACCORD FINTECH BSE Online News India, April 25 -- Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2016, inter alia, to consider & approve the audited ...
 HT Syndication1 week ago Cadila Healthcare's FY16 results on May 13, 2016  Money Control1 week ago Elder Healthcar's board meeting on April 06, 2016  Money Control1 month ago Sunil Healthcare: Outcome of independent directors meeting  Money Control1 month ago
[x]  

Fortis Healthcare gains after bulk deal

Fortis Healthcare rose 2.35% to Rs 182.65 at 14:44 IST on BSE after a bulk deal of 3.88 lakh shares was executed on the scrip at Rs 180.65 per share at 09:35 IST on BSE today, 12 April 2016. Meanwhile, the BSE Sensex was up 127.54 points, or ...
 Capital Market3 weeks ago Merck slides ex-dividend  KJMC Group1 week ago Malvinder Mohan Singh, Executive Chairman, Fortis Healthcare felicitated as "Entrepreneur of the Year"  Equity Bulls1 month ago
India Infoline

Lupin closes 2% lower despite marketing agreement with Novartis Healthcare

Shares of Lupin closed 1.51% lower at Rs. 1,517.50 on BSE despite the company's marketing agreement with Novartis Healthcare for Loftair. Lupin and Novartis Healthcare Pvt Ltd have entered into a co-marketing agreement to promote Novartis's ...
 India Infoline3 weeks ago Lupin to market new Inhaler under the brand name Loftair® in India  Equity Bulls3 weeks ago Lupin to market Novartis' inhaler under Loftair brand name  Moneycontrol.com3 weeks ago Lupin rises after report of Japan expansion plan  Sify2 months ago
Sify

Sensex Falls 49 Points In Early Trade

MUMBAI: The benchmark BSE Sensex fell 49 points in early trade on Tuesday, weighed down by losses in healthcare, IT and consumer durables, amid a weak trend in Asian markets. The 30-share index fell 48.84 points, or 0.19 percent, to 24,917.56. The gauge had ...
 Silicon India1 month ago Sensex falls 49 pts in early trade; healthcare, IT decline  Sify1 month ago Sensex down 70 pts in early trade on falling exports  Deccan Herald1 month ago Sensex down 61 points even as inflation at 3-month low  State Times1 month ago
[x]  
Economic Times

HealthCare Global sees weak debut

Shares of HealthCare Global Enterprises settled at Rs 170.95 on BSE, a discount of 21.58% compared with the initial public offer price of Rs 218 on its debut on the bourses today, 30 March 2016. The stock debuted at Rs 209.80 on BSE, a discount of 3.76% ...
 Business Standard1 month ago Healthcare Global lists at big discount to its issue price  Economic Times1 month ago
DNA

Cadila Healthcare gets USFDA nod to sell generic anti-viral drug

The company's shares were down 0.17% on the BSE.
 DNA1 month ago Zydus Cadila gets USFDA nod for cancer treatment drug  Economic Times1 month ago Glenmark gets two ANDA approvals from US FDA  Economic Times1 month ago Cadila gets USFDA nod to sell generic anti-viral drug  Economic Times1 month ago
[x]  
India Infoline

HealthCare Global Enterprises to debut on BSE today

 Religare Securities1 month ago HealthCare Global Enterprises list on BSE and NSE  India Infoline1 month ago HealthCare Global Enterprises makes lackluster debut  Business Standard1 month ago Healthcare Global, Bharat Wire IPOs to hit markets this week  DNA1 month ago

Cadila Healthcare gains after receiving tentative approval from USFDA for drug

Cadila Healthcare rose 1.22% to Rs 339.60 at 14:20 IST on BSE after the company received tentative approval from the USFDA to market Clofarabine Injection 20mg/20ml vials in the US.
 Business Standard1 month ago Cadila Healthcare rises 3% on USFDA approval for anticancer drug  Moneycontrol.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bse healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less